Pernix Therapeutics Holdings Inc. | Ownership
Companies that own Pernix Therapeutics Holdings Inc.
Deerfield Management Company LP
1,204,586
8.65%
1,204,586
0.04%
08/01/2018
Renaissance Technologies LLC
953,750
6.85%
12,500
0%
06/30/2018
The Vanguard Group, Inc.
374,217
2.69%
2,606
0%
06/30/2018
BlackRock Fund Advisors
219,883
1.58%
12,251
0%
06/30/2018
Jacobs Levy Equity Management, Inc.
87,643
0.63%
7,722
0%
06/30/2018
BMO Asset Management, Inc.
63,000
0.45%
60,000
0%
06/30/2018
Geode Capital Management LLC
47,126
0.34%
7,531
0%
06/30/2018
Cetera Investment Advisers LLC
46,750
0.34%
0
0.01%
06/30/2018
Northern Trust Investments, Inc.
16,699
0.12%
4,264
0%
06/30/2018
Goldman Sachs & Co. LLC (Private Banking)
15,008
0.11%
-693
0%
06/30/2018
| Address |
10 North Park Place
Morristown New Jersey 07960
United States
|
|
Employees
|
- |
| Website |
http://www.pernixtx.com |
| Updated |
09/14/2018 |
| Pernix Therapeutics Holdings, Inc. engages in the research, development, and manufacture of biopharmaceutical products. It focuses on therapeutics for diseases on central nervous system, neurology, pain, and psychiatry. Its products include treatment of migraine pain and inflammation, insomnia, and depressive disorder. |
